Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis

Ixekizumab significantly improves symptoms of psoriatic arthritis in patients naive to prior biologic therapy and in patients who had failed prior to biologic therapy.
FDA Approvals

http://ift.tt/2BPmQ5B